Black-Grass Resistance Gene Discovered
News Jul 08, 2013
BBSRC-funded scientists at the Universities of York and Durham have discovered a gene called AmGSTF1 that plays a key role in controlling multi-herbicide resistance (MHR) in black-grass and rye-grass. Chemicals that inhibit this gene can be used to make weed killers effective against resistant weeds.
Black-grass and rye-grass are both widespread and serious weed problems in cereal and oilseed rape rotations. Control using weed killers is becoming increasingly problematic, with an estimated 1.2 million ha of UK land now infested with black-grass. Both black-grass and rye-grass can acquire a single defence mechanism that confers resistance to all weed killers, whatever their mode of action (MHR).
The genetics of MHR has been little understood until now. But in recently published research, the scientists have shown that a gene producing an enzyme called glutathione transferase (GST) is responsible for switching on MHR. When the gene was transferred to thale cress, the transgenic plants became resistant. "GSTs are known to detoxify herbicides directly," explains project leader Professor Rob Edwards of the Centre for Novel Agricultural Products at the University of York, "but we believe that our gene works as a master switch that activates a wide range of protective mechanisms."
When sprayed with a GST- inhibiting chemical, resistant plants became susceptible to weed killers. Although the compound used in these experiments is not suitable for use as an agrochemical, this experiment demonstrates the potential of GST inhibitors to improve the effectiveness of weed killers against resistant black-grass and rye-grass.
Professor Edwards believes this to be an important development. "These weeds have developed resistance to every type of herbicide available to farmers and the problem is getting worse", he explains. "We have identified a group of compounds that could be applied along with existing weed-killers to restore the effective weed control we are currently losing". Professor Edwards' team are also developing a genetic test for AmGSTF1 that could provide the first reliable diagnosis of MHR, an important step in deciding on the right weed control strategy.
Researchers from the Spanish National Cancer Research Centre (CNIO) have shown in a new study that the gene therapy with telomerase that they have developed, and which has proven to be effective in mice against diseases caused by excessive telomere shortening and ageing, does not cause cancer or increase the risk of developing it, even in a cancer-prone setting.READ MORE
Scientists report a novel gene therapy that halts vision loss in a canine model of a blinding condition called autosomal dominant retinitis pigmentosa (adRP). The strategy could one day be used to slow or prevent vision loss in people with the disease. NEI is part of the National Institutes of Health.